Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip L Cohen

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Autoimmunity|October 16, 2020
Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's modelPhilip L Cohen, Amanda McCulloch
The Lancet. Rheumatology|October 19, 2020
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?Gaetano Zizzo, Philip L Cohen
Rheumatic Diseases Clinics of North America|July 21, 2004
Genetic models for the clearance of apoptotic cellsPhilip L Cohen, Roberto Caricchio
Journal of Inflammation (London, England)|May 15, 2015
The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarizationGaetano Zizzo, Philip L Cohen
Disease Markers|July 31, 2019
Gas6/TAM Receptors in Systemic Lupus ErythematosusPhilip L Cohen, Wen-Hai Shao
Arthritis Research & Therapy|March 5, 2011
Disturbances of apoptotic cell clearance in systemic lupus erythematosusWen-Hai Shao, Philip L Cohen
Expert Review of Clinical Immunology|April 1, 2014
The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targetsWen-Hai Shao, Philip L Cohen
European Journal of Immunology|March 25, 2005
p53 is required for spontaneous autoantibody production in B6/lpr lupus miceAnita P Kuan, Philip L Cohen
Current Protocols in Immunology|April 25, 2008
Animal models for SLEPhilip L Cohen, Michael A Maldonado
International Journal of Clinical Rheumatology|July 14, 2012
Living life without B cells: is repeated B-cell depletion a safe and effective long-term treatment plan for rheumatoid arthritis?David R Chen, Philip L Cohen
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Autoimmunity|October 16, 2020
Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's modelPhilip L Cohen, Amanda McCulloch
The Lancet. Rheumatology|October 19, 2020
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?Gaetano Zizzo, Philip L Cohen
Rheumatic Diseases Clinics of North America|July 21, 2004
Genetic models for the clearance of apoptotic cellsPhilip L Cohen, Roberto Caricchio
Journal of Inflammation (London, England)|May 15, 2015
The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarizationGaetano Zizzo, Philip L Cohen
Disease Markers|July 31, 2019
Gas6/TAM Receptors in Systemic Lupus ErythematosusPhilip L Cohen, Wen-Hai Shao
Arthritis Research & Therapy|March 5, 2011
Disturbances of apoptotic cell clearance in systemic lupus erythematosusWen-Hai Shao, Philip L Cohen
Expert Review of Clinical Immunology|April 1, 2014
The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targetsWen-Hai Shao, Philip L Cohen
European Journal of Immunology|March 25, 2005
p53 is required for spontaneous autoantibody production in B6/lpr lupus miceAnita P Kuan, Philip L Cohen
Current Protocols in Immunology|April 25, 2008
Animal models for SLEPhilip L Cohen, Michael A Maldonado
International Journal of Clinical Rheumatology|July 14, 2012
Living life without B cells: is repeated B-cell depletion a safe and effective long-term treatment plan for rheumatoid arthritis?David R Chen, Philip L Cohen
Pageof 6